Skip to main content
MLEC logo

Moolec Science SA

MLECNASDAQHealthcareBiotechnology

$1.68Today:- (-)1Y −80.82%

As of Oct 16, 2026 close

Market cap
$1.36M
P/E (TTM)
0.06
Forward P/E
-
Dividend yield
-
52-week range
$1.62$23.22
Volume (live)
-
Avg. volume (3M)
64.77K

Moolec Science SA (MLEC) Cash Flow Statement

In fiscal 2025 (fiscal year ended Jun 30, 2025), Moolec Science SA generated $3.64M of operating cash flow and spent $5.65M on capital expenditures. That left free cash flow of −$2.02M. It returned $998.95K to shareholders through $72.05K in dividends and $926.90K in share buybacks.

Moolec Science SA Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Moolec Science SA (MLEC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020
Period endingJun 2025Sep 2024Jun 2024Sep 2023Jun 2023Jun 2022Jun 2021Dec 2020
Operating Activities
Net Income-176.64-111.46-29.06-7.31-51.79-4.53-0.01-0.96
Depreciation & Amortization22.2522.2521.331.0119.510.000.00-
Deferred Income Tax6.646.641.10-1.05-2.330.860.00-
Stock Based Compensation4.394.3914.202.053.480.840.00-
Change in Working Capital42.8942.89-39.73-3.05-22.280.930.01-
Change in Accounts Receivable26.0428.08-41.260.27-0.040.000.00-
Change in Inventory34.8834.8815.29-5.79-8.570.000.00-
Change in Accounts Payable-18.85-18.8516.292.5014.170.930.000.06
Change in Other Working Capital2.04-1.2249.67-0.03-43.510.010.01-6.90
Other Operating Activities110.7515.2349.67-0.98-43.510.010.00-
Net Cash from Operating Activities3.64-24.4539.56-9.33-41.16-1.89-0.01-7.80
Investing Activities
Capital Expenditures-5.65-5.65-25.03-0.16-22.930.000.00-
Acquisitions-32.70-31.75-0.020.00-1.080.000.00-
Purchases of Investments-11.35-11.35-65.57-0.14-8.49-138.000.00-
Sales/Maturities of Investments21.7321.7362.840.441.320.000.00-
Other Investing Activities-32.14-8.610.020.000.000.000.00-
Net Cash from Investing Activities-35.99-35.99-27.400.13-25.59-138.000.00-
Financing Activities
Debt Repayment-380.0323.30-149.9210.91-42.310.000.30-
Common Stock Issued-0.002.1713.1110.012.000.037.80
Common Stock Repurchased-0.93-0.93-0.73-0.31-3.000.000.00-
Dividends Paid-0.070.00-0.170.000.000.000.00-
Other Financing Activities-37.32-9.30-2.03-1.38-3.462.00-0.31-
Net Cash from Financing Activities-15.0213.07-1.4911.7176.222.000.017.80
Summary
Effect of Forex Changes on Cash-4.85-4.85-6.750.345.13-0.010.00-
Net Change in Cash-47.37-52.2310.662.869.470.110.01-
Cash at Beginning of Period52.9952.9949.272.5334.850.980.00-
Cash at End of Period0.770.7752.995.3949.271.080.01-
Free Cash Flow-2.02-30.1014.53-9.49-64.09-1.89-0.01-7.80
Supplemental Disclosures
Interest Paid--0.57-0.02---

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Moolec Science SA Cash Flow

What is Moolec Science SA's free cash flow?

Moolec Science SA had negative free cash flow of $2.02M in fiscal 2025 (fiscal year ended Jun 30, 2025), operating cash flow of $3.64M minus $5.65M of capital expenditures.

How much does Moolec Science SA spend on capital expenditures?

Moolec Science SA spent $5.65M on capital expenditures in fiscal 2025, compared with $5.65M a year earlier. That equals 155.4% of operating cash flow.

Does Moolec Science SA pay dividends or buy back shares?

Yes. In fiscal 2025 Moolec Science SA returned $72.05K in dividends and $926.90K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition